Skip Nav Destination
Issue Highlights
- CD371/SAVVY/IL-18 CAR T cells for refractory AML
- Spotlight: anti-PD1 toxicities in cHL first-line therapy
- Acalabrutinib in older and frail patients with CLL
- Gene therapy with AAV-FVIII–mimetic antibody for hemophilia A
- Runx2 is a key regulator of HSC activity
- Germ line variation influences MPN phenotype
- How autoantibodies bind β2GPI in APS
Latest in Blood
Christine E. Ryan; Matthew S. Davids
Travis J. Fleming; Mateusz Antoszewski; Sander Lambo; Michael C. Gundry; Riccardo Piussi; Lara Wahlster; Sanjana Shah; Fiona E. Reed; Kevin D. Dong; Joao A. Paulo; Steven P. Gygi; Claudia Mimoso; Seth R. Goldman; Karen Adelman; Jennifer A. Perry; Yana Pikman; Kimberly Stegmaier; Maria N. Barrachina; Kellie R. Machlus; Volker Hovestadt; Andrea Arruda; Mark D. Minden; Richard A. Voit; Vijay G. Sankaran
p27Kip1 regulates γ-globin production
Available to Purchase
Ginette Balbin-Cuesta; Claire Drysdale; Claire Kerpet; Lei Yu; Greggory Myers; Zesen Lin; Beth McGee; Ann Friedman; Xiaofeng Liu; Sharon A. Singh; James Douglas Engel; Laura Buttitta; Rami Khoriaty
CD371-targeted CAR T cells secreting interleukin-18 exhibit robust expansion and clear refractory acute myeloid leukemia
Available to Purchase
Mark B. Geyer; Susan DeWolf; Xiaoli Mi; Kenyon Weis; Brian C. Shaffer; Briana Cadzin; Devin McAvoy; Zoe Katsamakis; Rachel Lorenc; Alexander M. Lewis; Brianna Gipson; M. Adriana Cuibus; Narina N. Girotra; Kenton Wu; Natalie Smith; Erin R. Burns; Jasmine S. Um; Sarah Yoo; Behzad Kharabi Masouleh; Pallavi Galera; Kinga Hosszu; Jagrutiben Chaudhari; Xiuyan Wang; Qianqian Lin; Kevin J. Curran; Jae H. Park; David A. Scheinberg; Marcel R. M. van den Brink; Omar Abdel-Wahab; Renier J. Brentjens; Anthony F. Daniyan
Advertisement intended for health care professionals





